CORRECTION: Director/PDMR Shareholding

RNS Number : 0497F

Judges Scientific PLC

12 November 2020

 

CORRECTION: Director/PDMR Shareholding

The following amendment has been made to the " Director/PDMR Shareholding" announcement released on 11/11/2020 at 16:48 under RNS No 0380F.

The original RNS stated that David Cicurel was benefically interested in 753,455 Ordinary Shares. This has now been corrected to 709,455 Ordinary Shares.

All other details remain unchanged. The full amended announcement is set out below.

Judges Scientific plc

(the "Company")

Director/PDMR Shareholding

In accordance with notification obligations under article 19.3 of the Market Abuse Regulation, the Company announces that on 10 November 2020 David Cicurel, CEO, transferred the beneficial interest in 6,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares") to the Shoftim Charitable Trust (the "Charity").

David Cicurel and Ralph Cohen, Non-Executive Director of Judges, are trustees of the Charity. Following this gift David Cicurel is benefically interested in 709,455 Ordinary Shares and is non-benefically interested in 50,000 Ordinary Shares.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Cicurel
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Judges Scientific plc
b)	LEI	2138004EXWWPTW1JOL31
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares in Judges Scientific plc GB0032398678
b)	Nature of the transaction	Gift beneficial interest in 6,000 Ordinary Shares to the Charity.
c)	Price(s) and volume(s)	Price(s) Volume(s) 0p 6,000
d)	Aggregated information - Aggregated volume - Price	N/A (single transaction)
e)	Date of the transaction	10/11/20
f)	Place of the transaction	Outside a trading venue

Judges Scientific
David Cicurel, CEO Brad Ormsby, Group FD	Tel: [phone]
Shore Capital (Nominated Adviser & Joint Broker) Stephane Auton Edward Mansfield Sarah Mather	Tel: [phone]
Liberum (Joint Broker) Bidhi Bhoma Euan Brown	Tel:  [phone]
Media enquiries : Alma PR (Financial Public Relations) Rebecca Sanders-Hewett Sam Modlin	Tel: [phone] [e-mail]

Notes to editors:  

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses.  The Group currently consists of 19 businesses acquired since it was re-admitted to AIM in 2005.  

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queens' awards for innovation and export. 

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, payment of increasing dividends and through organic growth which the Group encourages by creating an environment for businesses to thrive in, with support and advice for entity management teams. 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins. 

For further information, please visit www.judges.uk.com 

 

END

 

 

DSHGPGCAGUPUGRG